Budget 2017: PBS shake-up to cut cost of drugs

9 May 2017 - Price reforms in the Pharmaceutical Benefits Scheme will deliver $1.8 billion in savings over five years, ...

Read more →

Strategic Agreement between the Innovative pharmaceutical industry and government delivers certainty for industry, savings to taxpayers and benefits to patients

9 May 2017 - Medicines Australia has signed a strategic agreement with the Australian Government that will support ongoing access ...

Read more →

Drugs and manners of administration that meet the F2/multi-brand criteria (30 month clock for originator removal calculation) for the 2017 October Cycle

7 April 2017 - A list of drugs and manners of administration that meet the F2/multi-brand criteria (30 month clock for ...

Read more →

Payers’ experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia

1 April 2017 - Institutional payers for pharmaceuticals worldwide appear to be increasingly negotiating confidential discounts off of the official list ...

Read more →

The hidden cost keeping your health insurance premiums high

30 March 2017 - Private health insurance costs for everyone could drop dramatically if the Federal Government tackled murky practices relating ...

Read more →

Federal Government announce 1100 medicines to have prices cut including rosuvastatin

25 March 2017 - Sick Australians will save $500 million over four years and up to $200 a year each ...

Read more →

Battle over hips and the hip pocket as prostheses costs fight heats up

12 March 2017 - Australia's medical technology bodies are gearing up for battle as the cost of replacement hips, knees ...

Read more →

Confirmed prices – 2017 April cycle of price disclosure

10 March 2017 - Confirmed 1 April 2017 prices resulting from the 2017 April cycle of price disclosure have been published. ...

Read more →

Industry group versus California newcomer in medical technology price row

9 March 2017 - The industry lobby group representing medical device manufacturers has rejected claims by a US manufacturer that ...

Read more →

Drug pricing report shows scope for more savings

6 March 2017 - The savings to the taxpayer in reducing the cost to Government of prescribed pharmaceuticals has been ...

Read more →

Response to the Grattan Institute Report on medicine prices

6 March 2017 - Medicines Australia does not accept the findings of this latest inaccurate, selective and misleading Grattan Report ...

Read more →

Australians paying four times above international prices for drugs

5 March 2017 - Yet another report from the Grattan Institute on the prices of off-patent medicines in the PBS; ...

Read more →

Bupa head tackles government for further reductions on costly prostheses

9 February 2017 - Bupa is calling on the Turnbull government to further reform medical device prices as the health ...

Read more →

Health insurers seek a halt to ‘$800m prosthetics wastage’

8 February 2017 - Health insurers have renewed calls for the federal government to address the high cost of prostheses, ...

Read more →

Senate inquiry on prostheses pricing urged to consider implications

31 January 2017 - AusBiotech has made a submission to the Senate’s Community Affairs References Committee Inquiry into the ‘Price ...

Read more →